EGF and breast carcinoma: Consistently, in the present study, re-expression of the phosphor-mimicking mutant Anxa2 (Anxa2 Y23D), but not the phosphorylation-deficient Anxa2 (Anxa2 Y23A), in Anxa2-silencing breast cancer cells rescued EGF-induced EMT.